Search
for
Sort by
Research 121–150 of 1000+
- Characterization and causal investigations of an alopecia syndrome in Australian fur seals (<i>Arctocephalus pusillus doriferus</i>)
- The importance and use of stem cells in dermatology
- Adipose-Derived Stem/Stromal Cells
- Cosmetic Procedures in the Treatment of Alopecia
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Regenerative Medicine Approaches for Engineering a Human Hair Follicle
- Alopecia and Thyroid Disease
- Nutritional factors and hair loss
- Causes of hair loss and the developments in hair rejuvenation
- Telogen effluvium
- Low level laser therapy and hair regrowth: an evidence-based review
- Hair loss and herbs for treatment
- Morphological Approach to Hair Disorders
- Scalp hair diameter increases during pregnancy
- Management of Hair Loss in Women
- Female pattern hair loss
- Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair
- Techniques for the discovery and evaluation of drugs against alopecia
- Quantitative Studies on Human Hair Growth(I). Fundamental Measurements and the Evaluation of Hair Growers.
- A Segmental Approach to Scoring Hair Density from Global Images: Introducing the Scalp Coverage Scoring Method for Clinical Trials and Practice
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- SUMMARIES OF PAPERS
- Progenitor‐cell‐enriched micrografts as a novel option for the management of androgenetic alopecia
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial
- Lichen Planopilaris: Update on Diagnosis and Treatment
- Estrogens and aging skin
- Theoretical considerations in laser hair removal
- Frontal fibrosing alopecia: a survey in 16 patients
- Histopathology of non-scarring alopecia
- Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device–Controlled Multicenter Trial